GlassScriptPhysician profile
Kyle A Andrews
NPI 1053766360
$8,895.86
in general payments reported to CMS, 2019-2025
20 companies · $1,624 in 2025
The $1,624 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,534 · 2021: $1,169 · 2022: $2,363 · 2023: $1,269 · 2024: $937 · 2025: $1,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,595 · Travel and Lodging: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,595.32 |
| Travel and Lodging | $234.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,791.33 | 2021-2025 | Pro, Gamma, Mako |
| Exactech, INC. | $1,735.93 | 2022 | |
| Cdc Medical LLC | $1,447.00 | 2019 | |
| Integra Lifesciences Corporation | $1,100.77 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| My01 INC. | $666.17 | 2023-2025 | My01 Continuous Compartmental Pressure Monitor |
| Si-Bone, INC. | $560.66 | 2021-2025 | |
| Depuy Synthes Sales INC. | $402.83 | 2022-2025 | Tfn-Advance, Na |
| Zimmer Biomet Holdings, INC. | $236.84 | 2022-2024 | Accufill, Persona, Genex |
| Kerecis Limited | $202.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Nuvasive, INC. | $176.18 | 2023 | Reline |
| Bioventus LLC | $159.42 | 2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Ets Wound Care LLC | $118.11 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Vericel Corporation | $87.24 | 2019 | |
| Illuminoss Medical, INC. | $74.22 | 2024 | |
| Amgen INC. | $41.68 | 2024 | Evenity, Prolia |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $22.42 | 2021 | |
| Smith+Nephew, INC. | $21.76 | 2023 | Grafix Pl, Oasis |
| Polynovo North America LLC | $20.24 | 2024 | Novosorb Btm |
| Kci USA, INC. | $17.34 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena Restor Arthroform, Prevena |
| Radius Health, INC. | $13.36 | 2024 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.